From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: A clinical prediction model-based approach

Oral Oncol. 2019 Jan:88:172-179. doi: 10.1016/j.oraloncology.2018.11.031. Epub 2018 Dec 7.

Abstract

Objectives: Feeding tubes are placed unnecessarily in a proportion of head and neck cancer (HNC) patients treated with chemoradiotherapy (CRT) when prophylactic tube placement protocols are used. This may have a negative impact on the risk of long-term dysphagia. Reactive tube placement protocols, on the other hand, might result in weight loss and treatment interruption. The objective of this study is to identify patients at risk for prolonged tube dependency in order to implement a personalized strategy regarding proactive tube placement.

Materials and methods: A retrospective study was performed in a consecutive cohort of HNC patients treated with primary CRT for whom a reactive tube placement protocol was used. A prediction model was developed to predict prolonged (> 90 days) feeding tube dependency. Model performance and clinical net benefit of the model were assessed.

Results: Of the 336 included patients, 229 (68%) needed a feeding tube during CRT and 151 (45%) were prolonged feeding tube dependent. The prediction model includes the predictors pretreatment BMI, weight loss, Functional Oral Intake Scale and T-stage. Discriminatory ability is fair (area under the ROC-curve of 0.69) and calibration is adequate (Hosmer and Lemeshow test p = .254). The model shows net benefit over current practice for probability thresholds from 35 to 80%.

Conclusion: The developed model can be used to select patients for proactive feeding tube placement during primary CRT for HNC. The nomogram with easily obtainable parameters is a useful tool for clinicians to support shared decision making regarding proactive tube placement.

Keywords: Chemoradiotherapy; Head and neck cancer; Risk prediction; Tube feeding.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Body Mass Index
  • Chemoradiotherapy / adverse effects*
  • Clinical Decision-Making / methods
  • Deglutition Disorders / etiology
  • Enteral Nutrition / methods*
  • Female
  • Gastrostomy / methods*
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Intubation, Gastrointestinal / methods*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Patient Selection
  • Patient-Specific Modeling*
  • Precision Medicine / methods*
  • Retrospective Studies
  • Weight Loss
  • Xerostomia / etiology